Nektar Therapeutics (NKTR)
1.77
+0.17
(+10.62%)
USD |
NASDAQ |
May 10, 14:57
Nektar Therapeutics Shareholders Equity (Quarterly): 130.99M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 130.99M |
September 30, 2023 | 159.37M |
June 30, 2023 | 196.96M |
March 31, 2023 | 240.86M |
December 31, 2022 | 366.64M |
September 30, 2022 | 412.22M |
June 30, 2022 | 458.73M |
March 31, 2022 | 607.89M |
December 31, 2021 | 679.51M |
September 30, 2021 | 801.54M |
June 30, 2021 | 904.98M |
March 31, 2021 | 994.51M |
December 31, 2020 | 1.077B |
September 30, 2020 | 1.171B |
June 30, 2020 | 1.256B |
March 31, 2020 | 1.296B |
December 31, 2019 | 1.405B |
September 30, 2019 | 1.489B |
June 30, 2019 | 1.557B |
March 31, 2019 | 1.634B |
December 31, 2018 | 1.718B |
September 30, 2018 | 1.790B |
June 30, 2018 | 1.860B |
March 31, 2018 | 58.28M |
December 31, 2017 | 87.83M |
Date | Value |
---|---|
September 30, 2017 | 84.16M |
June 30, 2017 | 3.386M |
March 31, 2017 | 44.75M |
December 31, 2016 | 88.12M |
September 30, 2016 | -67.85M |
June 30, 2016 | -39.25M |
March 31, 2016 | -0.275M |
December 31, 2015 | 6.429M |
September 30, 2015 | 39.05M |
June 30, 2015 | 35.10M |
March 31, 2015 | 77.30M |
December 31, 2014 | 36.33M |
September 30, 2014 | 47.22M |
June 30, 2014 | -35.36M |
March 31, 2014 | -9.809M |
December 31, 2013 | -89.90M |
September 30, 2013 | -50.25M |
June 30, 2013 | -40.55M |
March 31, 2013 | -2.62M |
December 31, 2012 | 47.02M |
September 30, 2012 | 95.33M |
June 30, 2012 | 132.28M |
March 31, 2012 | 162.49M |
December 31, 2011 | 197.81M |
September 30, 2011 | 230.80M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
130.99M
Minimum
Dec 2023
1.557B
Maximum
Jun 2019
800.34M
Average
801.54M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
Stereotaxis Inc | 21.92M |
Vanda Pharmaceuticals Inc | 544.91M |
Cara Therapeutics Inc | 57.08M |
Avid Bioservices Inc | 180.17M |
Rigel Pharmaceuticals Inc | -28.64M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 398.03M |
Total Liabilities (Quarterly) | 267.05M |
Current Ratio | 6.450 |